C07D 261/20
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D261/20 (Condensed with carbocyclic rings or ring systems) appears on 615 US grants and 533 published applications in this corpus.
Search patents in C07D- Granted patents
- 615
- Published applications
- 533
- Assignees
- 293
- Inventors
- 1,851
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 6 | 0 |
| 1979 | 3 | 0 |
| 1980 | 5 | 0 |
| 1981 | 1 | 0 |
| 1982 | 6 | 0 |
| 1983 | 6 | 0 |
| 1984 | 5 | 0 |
| 1985 | 5 | 0 |
| 1986 | 8 | 0 |
| 1987 | 5 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 9 | 0 |
| 1992 | 8 | 0 |
| 1993 | 20 | 0 |
| 1994 | 8 | 0 |
| 1995 | 9 | 0 |
| 1996 | 36 | 0 |
| 1997 | 22 | 0 |
| 1998 | 16 | 0 |
| 1999 | 18 | 0 |
| 2000 | 18 | 0 |
| 2001 | 13 | 2 |
| 2002 | 10 | 12 |
| 2003 | 9 | 19 |
| 2004 | 10 | 33 |
| 2005 | 14 | 28 |
| 2006 | 14 | 34 |
| 2007 | 22 | 19 |
| 2008 | 10 | 28 |
| 2009 | 16 | 20 |
| 2010 | 17 | 29 |
| 2011 | 22 | 27 |
| 2012 | 19 | 27 |
| 2013 | 28 | 35 |
| 2014 | 24 | 19 |
| 2015 | 24 | 20 |
| 2016 | 18 | 19 |
| 2017 | 17 | 25 |
| 2018 | 22 | 17 |
| 2019 | 11 | 15 |
| 2020 | 11 | 14 |
| 2021 | 9 | 17 |
| 2022 | 14 | 20 |
| 2023 | 5 | 17 |
| 2024 | 7 | 5 |
| 2025 | 10 | 21 |
| 2026 | 7 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CSF1R kinase inhibitor and use thereof9 Jun 2026US 12,649,721 B2Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Condensed isoxazoline derivatives and their use as herbicides5 May 2026US 12,617,803 B2BASF SE
- Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof31 Mar 2026US 12,590,071 B2Korea Institute of Science and Technology
- Inhibitors of YAP/TAZ-TEAD oncoproteins, synthesis and use thereof24 Mar 2026US 12,583,815 B2BridGene Biosciences, Inc.
- Oral complement factor D inhibitors24 Feb 2026US 12,558,341 B2BioCryst Pharmaceuticals, Inc.
- Tetraline, phenylcyclobutane and phenylcyclopentane analogs as rxfp1 agonists10 Sep 2026US 2026/0265208 A1Bristol-Myers Squibb Company
- Heterocyclic propyl amine modulators of monoaminergic transporters23 Jul 2026US 2026/0209226 A1
- Aryl-containing amine compound, preparation method therefor and use thereof25 Jun 2026US 2026/0174739 A1Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Oral complement factor d inhibitors18 Jun 2026US 2026/0165999 A1BioCryst Pharmaceuticals, Inc.
- C7-fluoro substituted tetracycline compounds23 Apr 2026US 2026/0109665 A1Tetraphase Pharmaceuticals, Inc.
Most cited
By later US patents
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010
- Modulators of ATP-binding cassette transporters118US 7,598,412 B2Vertex Pharmaceuticals Incorporated · 2009
- Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics115US 5,364,866 AHoechst-Roussel Pharmaceuticals Inc. · 1994
- N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin97US 5,514,691 AImmunopharmaceutics, Inc. · 1996
- Sulfonamides and derivatives thereof that modulate the activity of endothelin91US 5,571,821 ATexas Biotechnology Corporation · 1996